Global De Novo Sequencing Supply, Demand and Key Producers, 2023-2029
The global De Novo Sequencing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global De Novo Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for De Novo Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of De Novo Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global De Novo Sequencing total market, 2018-2029, (USD Million)
Global De Novo Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: De Novo Sequencing total market, key domestic companies and share, (USD Million)
Global De Novo Sequencing revenue by player and market share 2018-2023, (USD Million)
Global De Novo Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global De Novo Sequencing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global De Novo Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World De Novo Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global De Novo Sequencing Market, By Region:
1. How big is the global De Novo Sequencing market?
2. What is the demand of the global De Novo Sequencing market?
3. What is the year over year growth of the global De Novo Sequencing market?
4. What is the total value of the global De Novo Sequencing market?
5. Who are the major players in the global De Novo Sequencing market?
6. What are the growth factors driving the market demand?
This report studies the global De Novo Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for De Novo Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of De Novo Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global De Novo Sequencing total market, 2018-2029, (USD Million)
Global De Novo Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: De Novo Sequencing total market, key domestic companies and share, (USD Million)
Global De Novo Sequencing revenue by player and market share 2018-2023, (USD Million)
Global De Novo Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global De Novo Sequencing total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global De Novo Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 10X Genomics Inc., Abcam Plc, Exeter Clinical Laboratory, Psomagen, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG and Eurofins Scientific SE, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World De Novo Sequencing market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global De Novo Sequencing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Genome Survey
- Gene Annotation
- Evolution Analysis
- Auxiliary Assembly
- Oncology
- Hereditary Disease Detection
- Life Science
- 10X Genomics Inc.
- Abcam Plc
- Exeter Clinical Laboratory
- Psomagen
- BGI Genomics Co. Ltd.
- Bio Rad Laboratories Inc.
- Danaher Corp.
- Eppendorf AG
- Eurofins Scientific SE
- F. Hoffmann-La Roche Ltd.
- CD Genomics
- Illumina
- qGenomics
1. How big is the global De Novo Sequencing market?
2. What is the demand of the global De Novo Sequencing market?
3. What is the year over year growth of the global De Novo Sequencing market?
4. What is the total value of the global De Novo Sequencing market?
5. Who are the major players in the global De Novo Sequencing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 De Novo Sequencing Introduction
1.2 World De Novo Sequencing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World De Novo Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World De Novo Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States De Novo Sequencing Market Size (2018-2029)
1.3.3 China De Novo Sequencing Market Size (2018-2029)
1.3.4 Europe De Novo Sequencing Market Size (2018-2029)
1.3.5 Japan De Novo Sequencing Market Size (2018-2029)
1.3.6 South Korea De Novo Sequencing Market Size (2018-2029)
1.3.7 ASEAN De Novo Sequencing Market Size (2018-2029)
1.3.8 India De Novo Sequencing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 De Novo Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 De Novo Sequencing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World De Novo Sequencing Consumption Value (2018-2029)
2.2 World De Novo Sequencing Consumption Value by Region
2.2.1 World De Novo Sequencing Consumption Value by Region (2018-2023)
2.2.2 World De Novo Sequencing Consumption Value Forecast by Region (2024-2029)
2.3 United States De Novo Sequencing Consumption Value (2018-2029)
2.4 China De Novo Sequencing Consumption Value (2018-2029)
2.5 Europe De Novo Sequencing Consumption Value (2018-2029)
2.6 Japan De Novo Sequencing Consumption Value (2018-2029)
2.7 South Korea De Novo Sequencing Consumption Value (2018-2029)
2.8 ASEAN De Novo Sequencing Consumption Value (2018-2029)
2.9 India De Novo Sequencing Consumption Value (2018-2029)
3 WORLD DE NOVO SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World De Novo Sequencing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global De Novo Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for De Novo Sequencing in 2022
3.2.3 Global Concentration Ratios (CR8) for De Novo Sequencing in 2022
3.3 De Novo Sequencing Company Evaluation Quadrant
3.4 De Novo Sequencing Market: Overall Company Footprint Analysis
3.4.1 De Novo Sequencing Market: Region Footprint
3.4.2 De Novo Sequencing Market: Company Product Type Footprint
3.4.3 De Novo Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: De Novo Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: De Novo Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: De Novo Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: De Novo Sequencing Consumption Value Comparison
4.2.1 United States VS China: De Novo Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: De Novo Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based De Novo Sequencing Companies and Market Share, 2018-2023
4.3.1 United States Based De Novo Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies De Novo Sequencing Revenue, (2018-2023)
4.4 China Based Companies De Novo Sequencing Revenue and Market Share, 2018-2023
4.4.1 China Based De Novo Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies De Novo Sequencing Revenue, (2018-2023)
4.5 Rest of World Based De Novo Sequencing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based De Novo Sequencing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies De Novo Sequencing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World De Novo Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Genome Survey
5.2.2 Gene Annotation
5.2.3 Evolution Analysis
5.2.4 Auxiliary Assembly
5.3 Market Segment by Type
5.3.1 World De Novo Sequencing Market Size by Type (2018-2023)
5.3.2 World De Novo Sequencing Market Size by Type (2024-2029)
5.3.3 World De Novo Sequencing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World De Novo Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Hereditary Disease Detection
6.2.3 Life Science
6.3 Market Segment by Application
6.3.1 World De Novo Sequencing Market Size by Application (2018-2023)
6.3.2 World De Novo Sequencing Market Size by Application (2024-2029)
6.3.3 World De Novo Sequencing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 10X Genomics Inc.
7.1.1 10X Genomics Inc. Details
7.1.2 10X Genomics Inc. Major Business
7.1.3 10X Genomics Inc. De Novo Sequencing Product and Services
7.1.4 10X Genomics Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 10X Genomics Inc. Recent Developments/Updates
7.1.6 10X Genomics Inc. Competitive Strengths & Weaknesses
7.2 Abcam Plc
7.2.1 Abcam Plc Details
7.2.2 Abcam Plc Major Business
7.2.3 Abcam Plc De Novo Sequencing Product and Services
7.2.4 Abcam Plc De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abcam Plc Recent Developments/Updates
7.2.6 Abcam Plc Competitive Strengths & Weaknesses
7.3 Exeter Clinical Laboratory
7.3.1 Exeter Clinical Laboratory Details
7.3.2 Exeter Clinical Laboratory Major Business
7.3.3 Exeter Clinical Laboratory De Novo Sequencing Product and Services
7.3.4 Exeter Clinical Laboratory De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Exeter Clinical Laboratory Recent Developments/Updates
7.3.6 Exeter Clinical Laboratory Competitive Strengths & Weaknesses
7.4 Psomagen
7.4.1 Psomagen Details
7.4.2 Psomagen Major Business
7.4.3 Psomagen De Novo Sequencing Product and Services
7.4.4 Psomagen De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Psomagen Recent Developments/Updates
7.4.6 Psomagen Competitive Strengths & Weaknesses
7.5 BGI Genomics Co. Ltd.
7.5.1 BGI Genomics Co. Ltd. Details
7.5.2 BGI Genomics Co. Ltd. Major Business
7.5.3 BGI Genomics Co. Ltd. De Novo Sequencing Product and Services
7.5.4 BGI Genomics Co. Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BGI Genomics Co. Ltd. Recent Developments/Updates
7.5.6 BGI Genomics Co. Ltd. Competitive Strengths & Weaknesses
7.6 Bio Rad Laboratories Inc.
7.6.1 Bio Rad Laboratories Inc. Details
7.6.2 Bio Rad Laboratories Inc. Major Business
7.6.3 Bio Rad Laboratories Inc. De Novo Sequencing Product and Services
7.6.4 Bio Rad Laboratories Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bio Rad Laboratories Inc. Recent Developments/Updates
7.6.6 Bio Rad Laboratories Inc. Competitive Strengths & Weaknesses
7.7 Danaher Corp.
7.7.1 Danaher Corp. Details
7.7.2 Danaher Corp. Major Business
7.7.3 Danaher Corp. De Novo Sequencing Product and Services
7.7.4 Danaher Corp. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Danaher Corp. Recent Developments/Updates
7.7.6 Danaher Corp. Competitive Strengths & Weaknesses
7.8 Eppendorf AG
7.8.1 Eppendorf AG Details
7.8.2 Eppendorf AG Major Business
7.8.3 Eppendorf AG De Novo Sequencing Product and Services
7.8.4 Eppendorf AG De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Eppendorf AG Recent Developments/Updates
7.8.6 Eppendorf AG Competitive Strengths & Weaknesses
7.9 Eurofins Scientific SE
7.9.1 Eurofins Scientific SE Details
7.9.2 Eurofins Scientific SE Major Business
7.9.3 Eurofins Scientific SE De Novo Sequencing Product and Services
7.9.4 Eurofins Scientific SE De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Eurofins Scientific SE Recent Developments/Updates
7.9.6 Eurofins Scientific SE Competitive Strengths & Weaknesses
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Details
7.10.2 F. Hoffmann-La Roche Ltd. Major Business
7.10.3 F. Hoffmann-La Roche Ltd. De Novo Sequencing Product and Services
7.10.4 F. Hoffmann-La Roche Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7.10.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.11 CD Genomics
7.11.1 CD Genomics Details
7.11.2 CD Genomics Major Business
7.11.3 CD Genomics De Novo Sequencing Product and Services
7.11.4 CD Genomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CD Genomics Recent Developments/Updates
7.11.6 CD Genomics Competitive Strengths & Weaknesses
7.12 Illumina
7.12.1 Illumina Details
7.12.2 Illumina Major Business
7.12.3 Illumina De Novo Sequencing Product and Services
7.12.4 Illumina De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Illumina Recent Developments/Updates
7.12.6 Illumina Competitive Strengths & Weaknesses
7.13 qGenomics
7.13.1 qGenomics Details
7.13.2 qGenomics Major Business
7.13.3 qGenomics De Novo Sequencing Product and Services
7.13.4 qGenomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 qGenomics Recent Developments/Updates
7.13.6 qGenomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 De Novo Sequencing Industry Chain
8.2 De Novo Sequencing Upstream Analysis
8.3 De Novo Sequencing Midstream Analysis
8.4 De Novo Sequencing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 De Novo Sequencing Introduction
1.2 World De Novo Sequencing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World De Novo Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World De Novo Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States De Novo Sequencing Market Size (2018-2029)
1.3.3 China De Novo Sequencing Market Size (2018-2029)
1.3.4 Europe De Novo Sequencing Market Size (2018-2029)
1.3.5 Japan De Novo Sequencing Market Size (2018-2029)
1.3.6 South Korea De Novo Sequencing Market Size (2018-2029)
1.3.7 ASEAN De Novo Sequencing Market Size (2018-2029)
1.3.8 India De Novo Sequencing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 De Novo Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 De Novo Sequencing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World De Novo Sequencing Consumption Value (2018-2029)
2.2 World De Novo Sequencing Consumption Value by Region
2.2.1 World De Novo Sequencing Consumption Value by Region (2018-2023)
2.2.2 World De Novo Sequencing Consumption Value Forecast by Region (2024-2029)
2.3 United States De Novo Sequencing Consumption Value (2018-2029)
2.4 China De Novo Sequencing Consumption Value (2018-2029)
2.5 Europe De Novo Sequencing Consumption Value (2018-2029)
2.6 Japan De Novo Sequencing Consumption Value (2018-2029)
2.7 South Korea De Novo Sequencing Consumption Value (2018-2029)
2.8 ASEAN De Novo Sequencing Consumption Value (2018-2029)
2.9 India De Novo Sequencing Consumption Value (2018-2029)
3 WORLD DE NOVO SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World De Novo Sequencing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global De Novo Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for De Novo Sequencing in 2022
3.2.3 Global Concentration Ratios (CR8) for De Novo Sequencing in 2022
3.3 De Novo Sequencing Company Evaluation Quadrant
3.4 De Novo Sequencing Market: Overall Company Footprint Analysis
3.4.1 De Novo Sequencing Market: Region Footprint
3.4.2 De Novo Sequencing Market: Company Product Type Footprint
3.4.3 De Novo Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: De Novo Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: De Novo Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: De Novo Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: De Novo Sequencing Consumption Value Comparison
4.2.1 United States VS China: De Novo Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: De Novo Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based De Novo Sequencing Companies and Market Share, 2018-2023
4.3.1 United States Based De Novo Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies De Novo Sequencing Revenue, (2018-2023)
4.4 China Based Companies De Novo Sequencing Revenue and Market Share, 2018-2023
4.4.1 China Based De Novo Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies De Novo Sequencing Revenue, (2018-2023)
4.5 Rest of World Based De Novo Sequencing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based De Novo Sequencing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies De Novo Sequencing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World De Novo Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Genome Survey
5.2.2 Gene Annotation
5.2.3 Evolution Analysis
5.2.4 Auxiliary Assembly
5.3 Market Segment by Type
5.3.1 World De Novo Sequencing Market Size by Type (2018-2023)
5.3.2 World De Novo Sequencing Market Size by Type (2024-2029)
5.3.3 World De Novo Sequencing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World De Novo Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Hereditary Disease Detection
6.2.3 Life Science
6.3 Market Segment by Application
6.3.1 World De Novo Sequencing Market Size by Application (2018-2023)
6.3.2 World De Novo Sequencing Market Size by Application (2024-2029)
6.3.3 World De Novo Sequencing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 10X Genomics Inc.
7.1.1 10X Genomics Inc. Details
7.1.2 10X Genomics Inc. Major Business
7.1.3 10X Genomics Inc. De Novo Sequencing Product and Services
7.1.4 10X Genomics Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 10X Genomics Inc. Recent Developments/Updates
7.1.6 10X Genomics Inc. Competitive Strengths & Weaknesses
7.2 Abcam Plc
7.2.1 Abcam Plc Details
7.2.2 Abcam Plc Major Business
7.2.3 Abcam Plc De Novo Sequencing Product and Services
7.2.4 Abcam Plc De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abcam Plc Recent Developments/Updates
7.2.6 Abcam Plc Competitive Strengths & Weaknesses
7.3 Exeter Clinical Laboratory
7.3.1 Exeter Clinical Laboratory Details
7.3.2 Exeter Clinical Laboratory Major Business
7.3.3 Exeter Clinical Laboratory De Novo Sequencing Product and Services
7.3.4 Exeter Clinical Laboratory De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Exeter Clinical Laboratory Recent Developments/Updates
7.3.6 Exeter Clinical Laboratory Competitive Strengths & Weaknesses
7.4 Psomagen
7.4.1 Psomagen Details
7.4.2 Psomagen Major Business
7.4.3 Psomagen De Novo Sequencing Product and Services
7.4.4 Psomagen De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Psomagen Recent Developments/Updates
7.4.6 Psomagen Competitive Strengths & Weaknesses
7.5 BGI Genomics Co. Ltd.
7.5.1 BGI Genomics Co. Ltd. Details
7.5.2 BGI Genomics Co. Ltd. Major Business
7.5.3 BGI Genomics Co. Ltd. De Novo Sequencing Product and Services
7.5.4 BGI Genomics Co. Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BGI Genomics Co. Ltd. Recent Developments/Updates
7.5.6 BGI Genomics Co. Ltd. Competitive Strengths & Weaknesses
7.6 Bio Rad Laboratories Inc.
7.6.1 Bio Rad Laboratories Inc. Details
7.6.2 Bio Rad Laboratories Inc. Major Business
7.6.3 Bio Rad Laboratories Inc. De Novo Sequencing Product and Services
7.6.4 Bio Rad Laboratories Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bio Rad Laboratories Inc. Recent Developments/Updates
7.6.6 Bio Rad Laboratories Inc. Competitive Strengths & Weaknesses
7.7 Danaher Corp.
7.7.1 Danaher Corp. Details
7.7.2 Danaher Corp. Major Business
7.7.3 Danaher Corp. De Novo Sequencing Product and Services
7.7.4 Danaher Corp. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Danaher Corp. Recent Developments/Updates
7.7.6 Danaher Corp. Competitive Strengths & Weaknesses
7.8 Eppendorf AG
7.8.1 Eppendorf AG Details
7.8.2 Eppendorf AG Major Business
7.8.3 Eppendorf AG De Novo Sequencing Product and Services
7.8.4 Eppendorf AG De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Eppendorf AG Recent Developments/Updates
7.8.6 Eppendorf AG Competitive Strengths & Weaknesses
7.9 Eurofins Scientific SE
7.9.1 Eurofins Scientific SE Details
7.9.2 Eurofins Scientific SE Major Business
7.9.3 Eurofins Scientific SE De Novo Sequencing Product and Services
7.9.4 Eurofins Scientific SE De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Eurofins Scientific SE Recent Developments/Updates
7.9.6 Eurofins Scientific SE Competitive Strengths & Weaknesses
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Details
7.10.2 F. Hoffmann-La Roche Ltd. Major Business
7.10.3 F. Hoffmann-La Roche Ltd. De Novo Sequencing Product and Services
7.10.4 F. Hoffmann-La Roche Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7.10.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.11 CD Genomics
7.11.1 CD Genomics Details
7.11.2 CD Genomics Major Business
7.11.3 CD Genomics De Novo Sequencing Product and Services
7.11.4 CD Genomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 CD Genomics Recent Developments/Updates
7.11.6 CD Genomics Competitive Strengths & Weaknesses
7.12 Illumina
7.12.1 Illumina Details
7.12.2 Illumina Major Business
7.12.3 Illumina De Novo Sequencing Product and Services
7.12.4 Illumina De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Illumina Recent Developments/Updates
7.12.6 Illumina Competitive Strengths & Weaknesses
7.13 qGenomics
7.13.1 qGenomics Details
7.13.2 qGenomics Major Business
7.13.3 qGenomics De Novo Sequencing Product and Services
7.13.4 qGenomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 qGenomics Recent Developments/Updates
7.13.6 qGenomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 De Novo Sequencing Industry Chain
8.2 De Novo Sequencing Upstream Analysis
8.3 De Novo Sequencing Midstream Analysis
8.4 De Novo Sequencing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World De Novo Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World De Novo Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World De Novo Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World De Novo Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World De Novo Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World De Novo Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World De Novo Sequencing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World De Novo Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World De Novo Sequencing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key De Novo Sequencing Players in 2022
Table 12. World De Novo Sequencing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global De Novo Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key De Novo Sequencing Player
Table 15. De Novo Sequencing Market: Company Product Type Footprint
Table 16. De Novo Sequencing Market: Company Product Application Footprint
Table 17. De Novo Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China De Novo Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China De Novo Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based De Novo Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies De Novo Sequencing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies De Novo Sequencing Revenue Market Share (2018-2023)
Table 23. China Based De Novo Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies De Novo Sequencing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies De Novo Sequencing Revenue Market Share (2018-2023)
Table 26. Rest of World Based De Novo Sequencing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies De Novo Sequencing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies De Novo Sequencing Revenue Market Share (2018-2023)
Table 29. World De Novo Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World De Novo Sequencing Market Size by Type (2018-2023) & (USD Million)
Table 31. World De Novo Sequencing Market Size by Type (2024-2029) & (USD Million)
Table 32. World De Novo Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World De Novo Sequencing Market Size by Application (2018-2023) & (USD Million)
Table 34. World De Novo Sequencing Market Size by Application (2024-2029) & (USD Million)
Table 35. 10X Genomics Inc. Basic Information, Area Served and Competitors
Table 36. 10X Genomics Inc. Major Business
Table 37. 10X Genomics Inc. De Novo Sequencing Product and Services
Table 38. 10X Genomics Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. 10X Genomics Inc. Recent Developments/Updates
Table 40. 10X Genomics Inc. Competitive Strengths & Weaknesses
Table 41. Abcam Plc Basic Information, Area Served and Competitors
Table 42. Abcam Plc Major Business
Table 43. Abcam Plc De Novo Sequencing Product and Services
Table 44. Abcam Plc De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abcam Plc Recent Developments/Updates
Table 46. Abcam Plc Competitive Strengths & Weaknesses
Table 47. Exeter Clinical Laboratory Basic Information, Area Served and Competitors
Table 48. Exeter Clinical Laboratory Major Business
Table 49. Exeter Clinical Laboratory De Novo Sequencing Product and Services
Table 50. Exeter Clinical Laboratory De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Exeter Clinical Laboratory Recent Developments/Updates
Table 52. Exeter Clinical Laboratory Competitive Strengths & Weaknesses
Table 53. Psomagen Basic Information, Area Served and Competitors
Table 54. Psomagen Major Business
Table 55. Psomagen De Novo Sequencing Product and Services
Table 56. Psomagen De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Psomagen Recent Developments/Updates
Table 58. Psomagen Competitive Strengths & Weaknesses
Table 59. BGI Genomics Co. Ltd. Basic Information, Area Served and Competitors
Table 60. BGI Genomics Co. Ltd. Major Business
Table 61. BGI Genomics Co. Ltd. De Novo Sequencing Product and Services
Table 62. BGI Genomics Co. Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BGI Genomics Co. Ltd. Recent Developments/Updates
Table 64. BGI Genomics Co. Ltd. Competitive Strengths & Weaknesses
Table 65. Bio Rad Laboratories Inc. Basic Information, Area Served and Competitors
Table 66. Bio Rad Laboratories Inc. Major Business
Table 67. Bio Rad Laboratories Inc. De Novo Sequencing Product and Services
Table 68. Bio Rad Laboratories Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bio Rad Laboratories Inc. Recent Developments/Updates
Table 70. Bio Rad Laboratories Inc. Competitive Strengths & Weaknesses
Table 71. Danaher Corp. Basic Information, Area Served and Competitors
Table 72. Danaher Corp. Major Business
Table 73. Danaher Corp. De Novo Sequencing Product and Services
Table 74. Danaher Corp. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Danaher Corp. Recent Developments/Updates
Table 76. Danaher Corp. Competitive Strengths & Weaknesses
Table 77. Eppendorf AG Basic Information, Area Served and Competitors
Table 78. Eppendorf AG Major Business
Table 79. Eppendorf AG De Novo Sequencing Product and Services
Table 80. Eppendorf AG De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Eppendorf AG Recent Developments/Updates
Table 82. Eppendorf AG Competitive Strengths & Weaknesses
Table 83. Eurofins Scientific SE Basic Information, Area Served and Competitors
Table 84. Eurofins Scientific SE Major Business
Table 85. Eurofins Scientific SE De Novo Sequencing Product and Services
Table 86. Eurofins Scientific SE De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Eurofins Scientific SE Recent Developments/Updates
Table 88. Eurofins Scientific SE Competitive Strengths & Weaknesses
Table 89. F. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 90. F. Hoffmann-La Roche Ltd. Major Business
Table 91. F. Hoffmann-La Roche Ltd. De Novo Sequencing Product and Services
Table 92. F. Hoffmann-La Roche Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 94. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 95. CD Genomics Basic Information, Area Served and Competitors
Table 96. CD Genomics Major Business
Table 97. CD Genomics De Novo Sequencing Product and Services
Table 98. CD Genomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CD Genomics Recent Developments/Updates
Table 100. CD Genomics Competitive Strengths & Weaknesses
Table 101. Illumina Basic Information, Area Served and Competitors
Table 102. Illumina Major Business
Table 103. Illumina De Novo Sequencing Product and Services
Table 104. Illumina De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Illumina Recent Developments/Updates
Table 106. qGenomics Basic Information, Area Served and Competitors
Table 107. qGenomics Major Business
Table 108. qGenomics De Novo Sequencing Product and Services
Table 109. qGenomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of De Novo Sequencing Upstream (Raw Materials)
Table 111. De Novo Sequencing Typical Customers
Table 1. World De Novo Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World De Novo Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World De Novo Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World De Novo Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World De Novo Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World De Novo Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World De Novo Sequencing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World De Novo Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World De Novo Sequencing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key De Novo Sequencing Players in 2022
Table 12. World De Novo Sequencing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global De Novo Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key De Novo Sequencing Player
Table 15. De Novo Sequencing Market: Company Product Type Footprint
Table 16. De Novo Sequencing Market: Company Product Application Footprint
Table 17. De Novo Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China De Novo Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China De Novo Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based De Novo Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies De Novo Sequencing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies De Novo Sequencing Revenue Market Share (2018-2023)
Table 23. China Based De Novo Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies De Novo Sequencing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies De Novo Sequencing Revenue Market Share (2018-2023)
Table 26. Rest of World Based De Novo Sequencing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies De Novo Sequencing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies De Novo Sequencing Revenue Market Share (2018-2023)
Table 29. World De Novo Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World De Novo Sequencing Market Size by Type (2018-2023) & (USD Million)
Table 31. World De Novo Sequencing Market Size by Type (2024-2029) & (USD Million)
Table 32. World De Novo Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World De Novo Sequencing Market Size by Application (2018-2023) & (USD Million)
Table 34. World De Novo Sequencing Market Size by Application (2024-2029) & (USD Million)
Table 35. 10X Genomics Inc. Basic Information, Area Served and Competitors
Table 36. 10X Genomics Inc. Major Business
Table 37. 10X Genomics Inc. De Novo Sequencing Product and Services
Table 38. 10X Genomics Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. 10X Genomics Inc. Recent Developments/Updates
Table 40. 10X Genomics Inc. Competitive Strengths & Weaknesses
Table 41. Abcam Plc Basic Information, Area Served and Competitors
Table 42. Abcam Plc Major Business
Table 43. Abcam Plc De Novo Sequencing Product and Services
Table 44. Abcam Plc De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abcam Plc Recent Developments/Updates
Table 46. Abcam Plc Competitive Strengths & Weaknesses
Table 47. Exeter Clinical Laboratory Basic Information, Area Served and Competitors
Table 48. Exeter Clinical Laboratory Major Business
Table 49. Exeter Clinical Laboratory De Novo Sequencing Product and Services
Table 50. Exeter Clinical Laboratory De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Exeter Clinical Laboratory Recent Developments/Updates
Table 52. Exeter Clinical Laboratory Competitive Strengths & Weaknesses
Table 53. Psomagen Basic Information, Area Served and Competitors
Table 54. Psomagen Major Business
Table 55. Psomagen De Novo Sequencing Product and Services
Table 56. Psomagen De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Psomagen Recent Developments/Updates
Table 58. Psomagen Competitive Strengths & Weaknesses
Table 59. BGI Genomics Co. Ltd. Basic Information, Area Served and Competitors
Table 60. BGI Genomics Co. Ltd. Major Business
Table 61. BGI Genomics Co. Ltd. De Novo Sequencing Product and Services
Table 62. BGI Genomics Co. Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BGI Genomics Co. Ltd. Recent Developments/Updates
Table 64. BGI Genomics Co. Ltd. Competitive Strengths & Weaknesses
Table 65. Bio Rad Laboratories Inc. Basic Information, Area Served and Competitors
Table 66. Bio Rad Laboratories Inc. Major Business
Table 67. Bio Rad Laboratories Inc. De Novo Sequencing Product and Services
Table 68. Bio Rad Laboratories Inc. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bio Rad Laboratories Inc. Recent Developments/Updates
Table 70. Bio Rad Laboratories Inc. Competitive Strengths & Weaknesses
Table 71. Danaher Corp. Basic Information, Area Served and Competitors
Table 72. Danaher Corp. Major Business
Table 73. Danaher Corp. De Novo Sequencing Product and Services
Table 74. Danaher Corp. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Danaher Corp. Recent Developments/Updates
Table 76. Danaher Corp. Competitive Strengths & Weaknesses
Table 77. Eppendorf AG Basic Information, Area Served and Competitors
Table 78. Eppendorf AG Major Business
Table 79. Eppendorf AG De Novo Sequencing Product and Services
Table 80. Eppendorf AG De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Eppendorf AG Recent Developments/Updates
Table 82. Eppendorf AG Competitive Strengths & Weaknesses
Table 83. Eurofins Scientific SE Basic Information, Area Served and Competitors
Table 84. Eurofins Scientific SE Major Business
Table 85. Eurofins Scientific SE De Novo Sequencing Product and Services
Table 86. Eurofins Scientific SE De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Eurofins Scientific SE Recent Developments/Updates
Table 88. Eurofins Scientific SE Competitive Strengths & Weaknesses
Table 89. F. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 90. F. Hoffmann-La Roche Ltd. Major Business
Table 91. F. Hoffmann-La Roche Ltd. De Novo Sequencing Product and Services
Table 92. F. Hoffmann-La Roche Ltd. De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 94. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 95. CD Genomics Basic Information, Area Served and Competitors
Table 96. CD Genomics Major Business
Table 97. CD Genomics De Novo Sequencing Product and Services
Table 98. CD Genomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. CD Genomics Recent Developments/Updates
Table 100. CD Genomics Competitive Strengths & Weaknesses
Table 101. Illumina Basic Information, Area Served and Competitors
Table 102. Illumina Major Business
Table 103. Illumina De Novo Sequencing Product and Services
Table 104. Illumina De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Illumina Recent Developments/Updates
Table 106. qGenomics Basic Information, Area Served and Competitors
Table 107. qGenomics Major Business
Table 108. qGenomics De Novo Sequencing Product and Services
Table 109. qGenomics De Novo Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of De Novo Sequencing Upstream (Raw Materials)
Table 111. De Novo Sequencing Typical Customers
LIST OF FIGURES
Figure 1. De Novo Sequencing Picture
Figure 2. World De Novo Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World De Novo Sequencing Total Market Size (2018-2029) & (USD Million)
Figure 4. World De Novo Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World De Novo Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 13. De Novo Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 16. World De Novo Sequencing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 18. China De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 23. India De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of De Novo Sequencing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for De Novo Sequencing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for De Novo Sequencing Markets in 2022
Figure 27. United States VS China: De Novo Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: De Novo Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World De Novo Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World De Novo Sequencing Market Size Market Share by Type in 2022
Figure 31. Genome Survey
Figure 32. Gene Annotation
Figure 33. Evolution Analysis
Figure 34. Auxiliary Assembly
Figure 35. World De Novo Sequencing Market Size Market Share by Type (2018-2029)
Figure 36. World De Novo Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World De Novo Sequencing Market Size Market Share by Application in 2022
Figure 38. Oncology
Figure 39. Hereditary Disease Detection
Figure 40. Life Science
Figure 41. De Novo Sequencing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. De Novo Sequencing Picture
Figure 2. World De Novo Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World De Novo Sequencing Total Market Size (2018-2029) & (USD Million)
Figure 4. World De Novo Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World De Novo Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company De Novo Sequencing Revenue (2018-2029) & (USD Million)
Figure 13. De Novo Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 16. World De Novo Sequencing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 18. China De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 23. India De Novo Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of De Novo Sequencing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for De Novo Sequencing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for De Novo Sequencing Markets in 2022
Figure 27. United States VS China: De Novo Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: De Novo Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World De Novo Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World De Novo Sequencing Market Size Market Share by Type in 2022
Figure 31. Genome Survey
Figure 32. Gene Annotation
Figure 33. Evolution Analysis
Figure 34. Auxiliary Assembly
Figure 35. World De Novo Sequencing Market Size Market Share by Type (2018-2029)
Figure 36. World De Novo Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World De Novo Sequencing Market Size Market Share by Application in 2022
Figure 38. Oncology
Figure 39. Hereditary Disease Detection
Figure 40. Life Science
Figure 41. De Novo Sequencing Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
